Project Grant HT94252310134
Award Date 9/30/23
Completion Date 9/29/24
Dollars Obligated $157K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
- The Defense Health Agency awarded Emory University a $305,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a novel therapeutic target for renal medullary carcinoma. The award period runs from July 1, 2023 to June 30, 2026. As a leading research university, Emory has a strong track record of delivering scientific research and public health services under federal grants and contracts. This award supports Emory's expertise in...
- The Defense Health Agency awarded Emory University a $160,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of April 1, 2023 through March 31, 2025. The grant will support GENOME-WIDE ANALYSES OF PROTEIN-DNA INTERACTION USING LONG-READ SEQUENCING. Through this funding, Emory University will conduct research using long-read sequencing to analyze protein-DNA interactions on a genome-wide scale. The Military Medical Research and Development...
- The Defense Health Agency awarded a $585,759 Project Grant to Emory University in Atlanta, Georgia under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 1, 2025 to August 31, 2028, is focused on "Targeting GPNMB to Improve Efficacy of CDK4/6 Inhibitors in ER+ Breast Cancer." As a major research institution, Emory University will leverage its expertise in biomedical research, cancer studies, and clinical trials to conduct this...
- Emory University was awarded a $159,929 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund whole-genome structural variation and CpG methylation analyses through long-read sequencing from April 1, 2023 to March 31, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical...
- Emory University will conduct research under a $1,255,611 Project Grant from the Defense Health Agency through the Military Medical Research and Development program. The three-year award beginning in April 2023 will fund research to define the molecular basis for immunogenicity of locally advanced prostate tumors resistant to androgen deprivation therapy. The CFDA 12.420 program supports basic, applied and advanced biomedical research to transform military and public health care through...
- This Project Grant, awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), provides $625,994 to Emory University to support research on novel cell therapy approaches for neuroblastoma. The project aims to advance the development of new treatments for this type of pediatric cancer, which is a priority area for military medical research. Emory University, a leading academic research institution, is well-positioned to conduct this work,...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $187,800.00 to Emory University to conduct research on "Enhancing Radiosensitivity in CHD5-Depleted Lung Adenocarcinoma Through Inhibition of Nonhomologous End Joining (NHEJ)." The research project, which has a performance period from Mar 15, 2025 to Mar 14, 2026, aims to investigate innovative medical solutions for transforming healthcare for military...
- Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for...
- Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for...
- This federal Project Grant award of $156,049.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Emory University in Atlanta, GA. The grant supports research to establish epigenetic markers in neurofibromatosis, with a performance period from October 1, 2025 to September 30, 2026. As a major academic research institution, Emory University leverages its expertise in biomedical research, neuroscience, and specialized...